Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.

Marques-Vidal P, Schmid R, Bochud M, Bastardot F, von Känel R, Paccaud F, Glaus J, Preisig M, Waeber G, Vollenweider P.

PLoS One. 2012;7(12):e51768. doi: 10.1371/journal.pone.0051768. Epub 2012 Dec 12.

2.

Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients.

Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO.

Cardiovasc Diabetol. 2012 Mar 13;11:24. doi: 10.1186/1475-2840-11-24.

3.

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

Kanaya AM, Wassel Fyr C, Vittinghoff E, Harris TB, Park SW, Goodpaster BH, Tylavsky F, Cummings SR.

Arch Intern Med. 2006 Feb 13;166(3):350-6.

PMID:
16476877
4.

Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes.

Julia C, Czernichow S, Charnaux N, Ahluwalia N, Andreeva V, Touvier M, Galan P, Fezeu L.

Diabetes Res Clin Pract. 2014 Aug;105(2):231-8. doi: 10.1016/j.diabres.2014.05.001. Epub 2014 May 17.

PMID:
24931702
5.

Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).

Marques-Vidal P, Bastardot F, von Känel R, Paccaud F, Preisig M, Waeber G, Vollenweider P.

Clin Endocrinol (Oxf). 2013 Feb;78(2):232-41. doi: 10.1111/j.1365-2265.2012.04384.x.

PMID:
22409372
6.

Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project.

Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJ.

Diabetes Care. 2008 Jul;31(7):1410-5. doi: 10.2337/dc08-0036. Epub 2008 Mar 13. Erratum in: Diabetes Care. 2008 Aug;31(8):1713.

7.

Association between inflammatory and obesity markers in a Swiss population-based sample (CoLaus Study).

Marques-Vidal P, Bochud M, Bastardot F, Lüscher T, Ferrero F, Gaspoz JM, Paccaud F, Urwyler A, von Känel R, Hock C, Waeber G, Preisig M, Vollenweider P.

Obes Facts. 2012;5(5):734-44. doi: 10.1159/000345045. Epub 2012 Oct 23.

8.

Inflammatory markers and risk of developing type 2 diabetes in women.

Hu FB, Meigs JB, Li TY, Rifai N, Manson JE.

Diabetes. 2004 Mar;53(3):693-700.

9.

Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.

Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD.

Diabetes Care. 2008 May;31(5):995-1000. doi: 10.2337/dc07-1569. Epub 2008 Jan 30.

PMID:
18235054
10.

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.

Luc G, Empana JP, Morange P, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Evans A, Kee F, Bingham A, Machez E, Ducimetiere P.

Int J Obes (Lond). 2010 Jan;34(1):118-26. doi: 10.1038/ijo.2009.204. Epub 2009 Oct 13.

PMID:
19823188
11.
12.

Incidence of diabetes and serum adipokines in Catalonian men: the ADIPOCAT study.

Sans S, Padró T, Tuomilehto J, Badimon L.

Ann Med. 2013 Feb;45(1):97-102. doi: 10.3109/07853890.2012.679958. Epub 2012 Apr 13.

PMID:
22497253
13.

Adipocytokine levels in genetically high risk for type 2 diabetes in the Indian population: a cross-sectional study.

Bose KS, Gupta SK, Vyas P.

Exp Diabetes Res. 2012;2012:386524. doi: 10.1155/2012/386524. Epub 2012 Nov 14.

14.

Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.

Hansen D, Dendale P, Beelen M, Jonkers RA, Mullens A, Corluy L, Meeusen R, van Loon LJ.

Eur J Appl Physiol. 2010 Jun;109(3):397-404. doi: 10.1007/s00421-010-1362-5. Epub 2010 Feb 4.

15.

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

Diabetes Care. 2006 Nov;29(11):2498-503.

PMID:
17065691
16.

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6. doi: 10.1111/j.1365-2265.2008.03306.x.

PMID:
18505467
17.

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata study.

Diabetes Care. 2003 Jul;26(7):2015-20.

PMID:
12832305
18.

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, Koenig W.

Arch Intern Med. 2003 Jan 13;163(1):93-9.

PMID:
12523922
19.
20.

Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

Kim CH, Park JY, Lee KU, Kim JH, Kim HK.

Diabetes Metab Res Rev. 2009 Jan;25(1):64-9. doi: 10.1002/dmrr.890.

PMID:
19065605

Supplemental Content

Support Center